On a day when Merck reported strong sales for its launch of pulmonary arterial hypertension (PAH) treatment Winrevair (sotatercept) and stalwart cancer medicine Keytruda, the positive news was overshadowed by the suddenly flat sales of Gardasil.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,